Loading data
FRSHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 838.81 m USD | 720.42 m USD | 596.43 m USD | 498 m USD | 371.02 m USD |
| Cost of revenue | 126.15 m USD | 113.33 m USD | 103.37 m USD | 95.77 m USD | 78.03 m USD |
| Gross profit | 712.66 m USD | 607.09 m USD | 493.06 m USD | 402.23 m USD | 292.99 m USD |
| Research and development expense | 163.21 m USD | 164.59 m USD | 137.76 m USD | 135.54 m USD | 120.41 m USD |
| Operating profit | 13.21 m USD | -138.61 m USD | -170.17 m USD | -233.37 m USD | -204.78 m USD |
| Profit before tax | 53.28 m USD | -90.84 m USD | -123.77 m USD | -220.79 m USD | -181.48 m USD |
| Income tax expense | -130.44 m USD | 4.53 m USD | 13.67 m USD | 11.34 m USD | 10.52 m USD |
| Net income (reported basis) | 183.7 m USD | -95.4 m USD | -137.4 m USD | -232.1 m USD | -192 m USD |
| Net income attributable to common shareholders | — | -95.37 m USD | -137.44 m USD | -232.13 m USD | -2.84 bn USD |
| Basic earnings per share | 0.63 USD/share | -0.32 USD/share | -0.47 USD/share | -0.82 USD/share | -21.73 USD/share |
| Diluted earnings per share | 0.63 USD/share | -0.32 USD/share | -0.47 USD/share | -0.82 USD/share | -21.73 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.